Publications
17
Citations
136
Est. group size
—
Recurring co-author estimate
Active years
48
Publishing since 1979
Typically publishes in teams of ~9 · 0% small-team papers (≤3 authors) · across 5 venues
- Assessing Real-world Natural History of Indolent Systemic Mastocytosis: Retrospective Matched Cohort Study from Mayo Clinic Electronic Health Records
Journal of Allergy and Clinical Immunology · 2025
- Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia
Leukemia Research · 2023
- Real-world management of targeted therapies in chronic lymphocytic leukemia
Journal of Oncology Pharmacy Practice · 2022
- Real-world analysis of the safety/tolerability of gilteritinib in combination with mold-active azole prophylaxis
Leukemia Research · 2022
- Multicenter evaluation of efficacy and toxicity of venetoclax‐based combinations in patients with accelerated and blast phase myeloproliferative neoplasms
American Journal of Hematology · 2021
- Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemia
Critical Reviews in Oncology/Hematology · 2019
- Journal of Clinical Oncology×4
- Journal of Oncology Pharmacy Practice×2
- Leukemia & lymphoma/Leukemia and lymphoma×2
- Leukemia Research×2
- Critical Reviews in Oncology/Hematology×1
- Nathaniel R. Wilson
Medicine · University of Michigan
- Chia-Jen Liu
Medicine · University of Michigan
- Kai He
Medicine · The Ohio State University
- Jing Liang
Medicine · The Ohio State University
- Kevin Ho
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile